Loading...

FITC anti-mouse CD3ε Antibody FITC anti-mouse CD3ε Antibody

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_FITC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
  • 145-2C11_FITC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100305 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100306 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  5. Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
  6. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  7. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  8. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  9. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  10. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  11. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  12. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  13. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  14. Jerome JR, et al. 2023. Int J Mol Sci. 24: . PubMed
  15. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  16. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  17. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  18. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  19. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  20. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  21. Brunner SM, et al. 2023. Int J Mol Sci. 24:. PubMed
  22. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  23. Stitzlein LM, et al. 2023. Front Neurol. 14:1112207. PubMed
  24. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  25. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  26. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  27. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  28. Schulteis R, et al. 2008. Blood. 112:4905. PubMed
  29. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  30. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  31. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  32. Fornari T, et al. 2015. PLoS One. 10: 0142688. PubMed
  33. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  34. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  35. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  36. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  37. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  38. Lou F, et al. 2020. STAR Protoc. 1:100115. PubMed
  39. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  40. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  41. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  42. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  43. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  44. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  45. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  46. Patnode M, et al. 2013. Glycobiology. 23:381. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  49. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  50. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  51. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  52. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  53. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  54. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  55. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  56. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  57. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  58. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  59. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  60. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  61. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  62. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  63. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  64. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  65. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  66. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  67. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  68. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  69. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  70. He L, et al. 2019. iScience. 0.790972222. PubMed
  71. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  72. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  73. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  74. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  77. Tang CC, et al. 2021. eLife. 10:00. PubMed
  78. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  79. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  80. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  81. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  82. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  83. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  84. Yang H, et al. 2022. Nutrients. 14:. PubMed
  85. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  86. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  87. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  88. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  89. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  90. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  91. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  92. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  93. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  94. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  95. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  96. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  97. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  98. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  99. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  100. Bian G, et al. 2020. British Journal of Pharmacology. 178(3):636-653. PubMed
  101. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  102. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  103. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  104. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  105. Xu M, et al. 2013. J Immunol. 190:5436. PubMed
  106. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  107. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  108. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  109. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  110. Labiano S, et al. 2017. Oncoimmunology. 6:e1283468. PubMed
  111. Engblom C, et al. 2017. Science. 358:6367. PubMed
  112. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  113. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  114. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  115. Yue W, et al. 2019. Nat Commun. 10:2025. PubMed
  116. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  117. Lind L, et al. 2021. J Neurovirol. 27:145. PubMed
  118. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  119. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  120. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  121. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  122. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  123. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  124. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  125. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  126. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  127. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  128. Lin JC, et al. 2019. Nat Commun. 10:1057. PubMed
  129. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  130. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  131. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  132. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  133. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  134. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  135. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  136. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  137. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  138. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  139. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  140. Sheng J, et al. 2021. eLife. 10:00. PubMed
  141. Nakagawa Y, et al. 2015. Immunol Lett. 167: 72-86. PubMed
  142. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  143. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  144. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  145. Schofield L, et al. 2017. BMC Med. 10.1186/s12916-017-0883-8. PubMed
  146. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  147. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  148. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  149. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  150. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  151. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  152. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  153. Zhou X, et al. 2021. Nutr Metab (Lond). 18:64. PubMed
  154. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  155. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  156. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  157. Amatruda M, et al. 2022. Brain Commun. 4:fcac044. PubMed
  158. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  159. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
  160. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  161. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  162. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  163. Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
  164. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  165. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  166. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  167. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  168. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  169. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  170. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  171. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  172. Jerome JR, et al. 2023. Int J Mol Sci. 24: . PubMed
  173. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  174. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  175. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  176. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  177. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  178. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  179. Brunner SM, et al. 2023. Int J Mol Sci. 24:. PubMed
  180. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  181. Stitzlein LM, et al. 2023. Front Neurol. 14:1112207. PubMed
  182. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  183. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  184. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  185. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  186. Schulteis R, et al. 2008. Blood. 112:4905. PubMed
  187. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  188. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  189. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  190. Fornari T, et al. 2015. PLoS One. 10: 0142688. PubMed
  191. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  192. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  193. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  194. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  196. Lou F, et al. 2020. STAR Protoc. 1:100115. PubMed
  197. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  198. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  199. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  200. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  201. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  202. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  203. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  204. Patnode M, et al. 2013. Glycobiology. 23:381. PubMed
  205. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  206. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  207. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  208. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  209. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  210. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  211. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  212. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  213. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  214. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  215. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  216. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  217. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  218. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  219. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  220. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  221. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  222. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  223. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  224. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  225. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  226. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  227. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  228. He L, et al. 2019. iScience. 0.790972222. PubMed
  229. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  230. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  231. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  232. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  233. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  234. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  235. Tang CC, et al. 2021. eLife. 10:00. PubMed
  236. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  237. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  238. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  239. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  240. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  241. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  242. Yang H, et al. 2022. Nutrients. 14:. PubMed
  243. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  244. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  245. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  246. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  247. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  248. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  249. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  250. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  251. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  252. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  253. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  254. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  255. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  256. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  257. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  258. Bian G, et al. 2020. British Journal of Pharmacology. 178(3):636-653. PubMed
  259. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  260. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  261. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  262. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  263. Xu M, et al. 2013. J Immunol. 190:5436. PubMed
  264. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  265. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  266. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  267. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  268. Labiano S, et al. 2017. Oncoimmunology. 6:e1283468. PubMed
  269. Engblom C, et al. 2017. Science. 358:6367. PubMed
  270. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  271. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  272. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  273. Yue W, et al. 2019. Nat Commun. 10:2025. PubMed
  274. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  275. Lind L, et al. 2021. J Neurovirol. 27:145. PubMed
  276. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  277. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  278. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  279. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  280. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  281. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  282. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  283. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  284. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  285. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  286. Lin JC, et al. 2019. Nat Commun. 10:1057. PubMed
  287. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  288. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  289. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  290. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  291. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  292. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  293. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  294. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  295. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  296. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  297. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  298. Sheng J, et al. 2021. eLife. 10:00. PubMed
  299. Nakagawa Y, et al. 2015. Immunol Lett. 167: 72-86. PubMed
  300. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  301. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  302. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  303. Schofield L, et al. 2017. BMC Med. 10.1186/s12916-017-0883-8. PubMed
  304. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  305. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  306. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  307. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  308. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  309. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  310. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  311. Zhou X, et al. 2021. Nutr Metab (Lond). 18:64. PubMed
  312. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  313. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  314. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  315. Amatruda M, et al. 2022. Brain Commun. 4:fcac044. PubMed
  316. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
RRID
AB_312670 (BioLegend Cat. No. 100305)
AB_312671 (BioLegend Cat. No. 100306)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
145-2C11 (See other available formats)
Regulatory Status
RUO
Other Names
CD3ε, T3, CD3
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
145-2C11_FITC_021606
C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
  • 145-2C11_FITC_021606
    C57BL/6 mouse splenocytes were stained with CD3e (clone 145-2C11) FITC and CD127 (clone SB/199) PE.
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100305 50 µg DKK179
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100306 500 µg DKK589
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32,  and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block)
  2. Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ)
  3. Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1.
  4. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB)
  5. Payer E, et al. 1991. J. Immunol. 146:2536. (IF)
  6. Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD)
  7. Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ)
  8. Henrickson M, et al. 1995. Transplantation 60:828. (Deplete)
  9. Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete)
  10. Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete)
  11. Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block)
  12. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ)
  13. Ko SY, et al. 2005. J. Immunol. 175:3309.
  14. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F)
  15. Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F)
  16. Wang W, et al. 2007. J. Immunol. 178:4885. (Activ)
  17. Xiao S, et al. 2007. J. Exp. Med. 204:1691.
  18. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed.
  19. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed
  20. Guo Y, et al. 2008. Blood 112:480. PubMed
  21. Kenna TJ, et al. 2008. Blood 111:2091.
  22. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed
  23. Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed
  24. Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed
  25. de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed
  26. Schulteis RD, et al. 2008. Blood 295:G273. PubMed
  27. Qi Q, et al. 2009. Blood 114:564. PubMed
  28. Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed
  29. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  30. Yan J, et al. 2014. Vaccine. 32:2833. PubMed
  31. Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed
  32. Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations
  1. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  5. Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
  6. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  7. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  8. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  9. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  10. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  11. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  12. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  13. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  14. Jerome JR, et al. 2023. Int J Mol Sci. 24: . PubMed
  15. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  16. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  17. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  18. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  19. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  20. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  21. Brunner SM, et al. 2023. Int J Mol Sci. 24:. PubMed
  22. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  23. Stitzlein LM, et al. 2023. Front Neurol. 14:1112207. PubMed
  24. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  25. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  26. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  27. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  28. Schulteis R, et al. 2008. Blood. 112:4905. PubMed
  29. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  30. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  31. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  32. Fornari T, et al. 2015. PLoS One. 10: 0142688. PubMed
  33. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  34. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  35. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  36. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  37. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  38. Lou F, et al. 2020. STAR Protoc. 1:100115. PubMed
  39. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  40. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  41. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  42. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  43. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  44. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  45. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  46. Patnode M, et al. 2013. Glycobiology. 23:381. PubMed
  47. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  48. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  49. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  50. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  51. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  52. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  53. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  54. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  55. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  56. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  57. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  58. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  59. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  60. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  61. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  62. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  63. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  64. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  65. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  66. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  67. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  68. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  69. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  70. He L, et al. 2019. iScience. 0.790972222. PubMed
  71. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  72. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  73. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  74. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  75. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  76. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  77. Tang CC, et al. 2021. eLife. 10:00. PubMed
  78. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  79. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  80. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  81. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  82. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  83. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  84. Yang H, et al. 2022. Nutrients. 14:. PubMed
  85. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  86. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  87. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  88. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  89. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  90. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  91. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  92. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  93. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  94. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  95. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  96. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  97. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  98. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  99. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  100. Bian G, et al. 2020. British Journal of Pharmacology. 178(3):636-653. PubMed
  101. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  102. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  103. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  104. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  105. Xu M, et al. 2013. J Immunol. 190:5436. PubMed
  106. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  107. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  108. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  109. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  110. Labiano S, et al. 2017. Oncoimmunology. 6:e1283468. PubMed
  111. Engblom C, et al. 2017. Science. 358:6367. PubMed
  112. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  113. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  114. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  115. Yue W, et al. 2019. Nat Commun. 10:2025. PubMed
  116. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  117. Lind L, et al. 2021. J Neurovirol. 27:145. PubMed
  118. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  119. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  120. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  121. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  122. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  123. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  124. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  125. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  126. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  127. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  128. Lin JC, et al. 2019. Nat Commun. 10:1057. PubMed
  129. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  130. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  131. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  132. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  133. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  134. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  135. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  136. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  137. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  138. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  139. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  140. Sheng J, et al. 2021. eLife. 10:00. PubMed
  141. Nakagawa Y, et al. 2015. Immunol Lett. 167: 72-86. PubMed
  142. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  143. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  144. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  145. Schofield L, et al. 2017. BMC Med. 10.1186/s12916-017-0883-8. PubMed
  146. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  147. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  148. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  149. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  150. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  151. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  152. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  153. Zhou X, et al. 2021. Nutr Metab (Lond). 18:64. PubMed
  154. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  155. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  156. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  157. Amatruda M, et al. 2022. Brain Commun. 4:fcac044. PubMed
  158. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  159. Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
  160. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  161. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  162. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  163. Chei S, et al. 2020. Front Nutr. 7:583186. PubMed
  164. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  165. Li DD, et al. 2022. J Cell Mol Med. 26:2438. PubMed
  166. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  167. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  168. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  169. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  170. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  171. Murakata Y, et al. 2023. Front Cardiovasc Med. 9:1075358. PubMed
  172. Jerome JR, et al. 2023. Int J Mol Sci. 24: . PubMed
  173. Drijvers JM, et al. 2021. Cancer Immunol Res. 9:184. PubMed
  174. Glorieux C, et al. 2022. J Adv Res. 40:109. PubMed
  175. Wu R, et al. 2022. Nat Immunol. 23:1536. PubMed
  176. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  177. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  178. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  179. Brunner SM, et al. 2023. Int J Mol Sci. 24:. PubMed
  180. Senatus L, et al. 2023. Commun Biol. 6:280. PubMed
  181. Stitzlein LM, et al. 2023. Front Neurol. 14:1112207. PubMed
  182. van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed
  183. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  184. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  185. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  186. Schulteis R, et al. 2008. Blood. 112:4905. PubMed
  187. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  188. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  189. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  190. Fornari T, et al. 2015. PLoS One. 10: 0142688. PubMed
  191. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  192. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  193. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  194. Kremenovic M, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. Tian H, et al. 2022. Cancer Sci. 113:875. PubMed
  196. Lou F, et al. 2020. STAR Protoc. 1:100115. PubMed
  197. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  198. Gruber T, et al. 2020. JCI Insight. 5:00. PubMed
  199. Allegrezza M, et al. 2016. Cancer Res . 76: 6253 - 6265. PubMed
  200. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  201. Isoda T et al. 2017. Cell. 171(1):103-119 . PubMed
  202. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  203. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  204. Patnode M, et al. 2013. Glycobiology. 23:381. PubMed
  205. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  206. Hoffman D, et al. 2021. Immunity. 54:2712. PubMed
  207. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  208. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  209. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  210. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  211. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  212. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  213. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  214. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  215. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  216. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  217. Collin R, et al. 2014. J Immunol. 193:3503. PubMed
  218. Yin Q, et al. 2015. PLoS One. 10: 0137808. PubMed
  219. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  220. Matsumura K, et al. 2016. J Immunol. 197: 3233 - 3244. PubMed
  221. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  222. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  223. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  224. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  225. Kawakami R, et al. 2021. Immunity. 54(5):947-961.e8. PubMed
  226. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  227. Skeate JG, et al. 2018. PLoS One. 13:e0191311. PubMed
  228. He L, et al. 2019. iScience. 0.790972222. PubMed
  229. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  230. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  231. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  232. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  233. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  234. Miki Y, et al. 2016. J Biol Chem. 291: 15588 - 15601. PubMed
  235. Tang CC, et al. 2021. eLife. 10:00. PubMed
  236. Gong Y, et al. 2020. Cell Metabolism. 33(1):51-64.e9. PubMed
  237. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  238. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  239. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  240. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  241. Pardy RD, et al. 2021. Nat Commun. 12:4051. PubMed
  242. Yang H, et al. 2022. Nutrients. 14:. PubMed
  243. Kondratieva T, et al. 2020. PLoS One. 15:e0239668. PubMed
  244. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  245. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  246. Stotesbury C, et al. 2020. J Immunol. 204:1582. PubMed
  247. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  248. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  249. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  250. Siamishi I, et al. 2020. Cell Reports. 31(11):107756. PubMed
  251. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  252. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  253. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  254. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  255. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  256. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  257. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  258. Bian G, et al. 2020. British Journal of Pharmacology. 178(3):636-653. PubMed
  259. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  260. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  261. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  262. Kim MY, et al. 2017. Plant Biotechnol J. 1.729166667. PubMed
  263. Xu M, et al. 2013. J Immunol. 190:5436. PubMed
  264. Huang J, et al. 2014. J Immunol. 192:1972. PubMed
  265. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  266. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  267. Vacca F, et al. 2020. eLife. 9:e54017.. PubMed
  268. Labiano S, et al. 2017. Oncoimmunology. 6:e1283468. PubMed
  269. Engblom C, et al. 2017. Science. 358:6367. PubMed
  270. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  271. Kang YH, et al. 2019. Nat Commun. 10:912. PubMed
  272. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  273. Yue W, et al. 2019. Nat Commun. 10:2025. PubMed
  274. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  275. Lind L, et al. 2021. J Neurovirol. 27:145. PubMed
  276. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  277. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  278. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  279. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  280. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  281. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  282. Luo L, et al. 2021. J Neuroinflammation. 18:27. PubMed
  283. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  284. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  285. Wang J, et al. 2019. Aging (Albany NY). 11:3463. PubMed
  286. Lin JC, et al. 2019. Nat Commun. 10:1057. PubMed
  287. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  288. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  289. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  290. Okuyama Y, et al. 2020. FASEB J. 540:34. PubMed
  291. La Salvia S, et al. 2020. Am J Physiol Renal Physiol. 319:F868. PubMed
  292. Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed
  293. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  294. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  295. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  296. Ma C, et al. 2021. Mol Metab. 47:101170. PubMed
  297. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  298. Sheng J, et al. 2021. eLife. 10:00. PubMed
  299. Nakagawa Y, et al. 2015. Immunol Lett. 167: 72-86. PubMed
  300. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  301. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  302. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  303. Schofield L, et al. 2017. BMC Med. 10.1186/s12916-017-0883-8. PubMed
  304. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  305. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  306. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  307. Kanaya T, et al. 2008. Am J Physiol Gastrointest Liver Physiol. 295:273. PubMed
  308. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  309. L M, et al. 2016. Brain. 139: 1939-1957. PubMed
  310. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  311. Zhou X, et al. 2021. Nutr Metab (Lond). 18:64. PubMed
  312. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  313. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  314. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  315. Amatruda M, et al. 2022. Brain Commun. 4:fcac044. PubMed
  316. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
RRID
AB_312670 (BioLegend Cat. No. 100305)
AB_312671 (BioLegend Cat. No. 100306)

Antigen Details

Structure
Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor
Peptide antigen/MHC-complex
Cell Type
NKT cells, T cells, Thymocytes, Tregs
Biology Area
Immunology
Molecular Family
CD Molecules, TCRs
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12501 View all products for this Gene ID
UniProt
View information about CD3epsilon on UniProt.org

Other Formats

View All CD3ε Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse CD3ε 145-2C11 FC
PE/Dazzle™ 594 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε (Maxpar® Ready) 145-2C11 FC,CyTOF®
Brilliant Violet 510™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 605™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 711™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 785™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 750 anti-mouse CD3ε 145-2C11 FC
GoInVivo™ Purified anti-mouse CD3ε 145-2C11 FC
APC anti-mouse CD3ε 145-2C11 FC
Biotin anti-mouse CD3ε 145-2C11 FC,IHC-F
FITC anti-mouse CD3ε 145-2C11 FC
PE anti-mouse CD3ε 145-2C11 FC
PE/Cyanine5 anti-mouse CD3ε 145-2C11 FC
Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Alexa Fluor® 488 anti-mouse CD3ε 145-2C11 FC
Alexa Fluor® 647 anti-mouse CD3ε 145-2C11 FC,IHC-F,3D IHC
PerCP anti-mouse CD3ε 145-2C11 FC
PerCP/Cyanine5.5 anti-mouse CD3ε 145-2C11 FC
APC/Cyanine7 anti-mouse CD3ε 145-2C11 FC
Pacific Blue™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 421™ anti-mouse CD3ε 145-2C11 FC,ICC
Ultra-LEAF™ Purified anti-mouse CD3ε 145-2C11 FC,IHC-F,IP,Activ,Block,WB,ICC
Spark YG™ 593 anti-mouse CD3 145-2C11 FC
PerCP/Fire™ 780 anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 650™ anti-mouse CD3ε 145-2C11 FC
Brilliant Violet 750™ anti-mouse CD3ε 145-2C11 FC
APC/Fire™ 810 anti-mouse CD3ε Antibody 145-2C11 FC
Spark YG™ 581 anti-mouse CD3ε (Flexi-Fluor™) 145-2C11 FC
Spark NIR™ 685 anti-mouse CD3ε (Flexi-Fluor™) Antibody 145-2C11 FC
PE/Fire™ 640 anti-mouse CD3ε 145-2C11
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account